AtriCure reports Q4 EPS (8c), consensus (15c)

Reports Q4revenue $124.3M, consensus $121.8M. “2024 was another outstanding year at AtriCure (ATRC), marked by continued progress on driving growth, improving profitability, and the introduction of several meaningful product launches across our key franchises,” said Michael Carrel, President and Chief Executive Officer at AtriCure. “With the breadth and performance of our business, I am optimistic for the future of AtriCure and look forward to sharing our pipeline and financial outlook at our Analyst and Investor Day in March.”